0001261974-26-000002.txt : 20260202 0001261974-26-000002.hdr.sgml : 20260202 20260202175334 ACCESSION NUMBER: 0001261974-26-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260130 FILED AS OF DATE: 20260202 DATE AS OF CHANGE: 20260202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY MARY ANN CENTRAL INDEX KEY: 0001261974 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 26589254 MAIL ADDRESS: STREET 1: 201 W 70TH ST, SUITE 23K CITY: NEW YORK STATE: NY ZIP: 10023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 form4-02022026_100231.xml X0508 4 2026-01-30 0001673772 RAPT Therapeutics, Inc. RAPT 0001261974 GRAY MARY ANN C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 true false false false 0 Common Stock 2026-01-30 4 A 0 4956 0 A 4956 D Represents the annual grant of restricted stock units ("RSUs") under the Issuer's Amended & Restated Non-Employee Director Compensation Policy, as currently in effect, which fully vest on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of common stock upon vesting. /s/ Rodney Young, Attorney-in-Fact 2026-02-02